Mizolastine 10mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10mg

Reference Brands: Mizollen (EU)

Category: Allergy Medication

Mizolastine is a second-generation, non-sedating antihistamine that selectively blocks peripheral H1 receptors. It is primarily indicated for the treatment of allergic rhinitis (seasonal & perennial) and chronic idiopathic urticaria, providing long-lasting relief from itching, sneezing, runny nose, and hives without significant drowsiness.

Product Description:

Mizolastine is a second-generation antihistamine that selectively antagonises peripheral H1 receptors with minimal central nervous system penetration, so sedation is uncommon at therapeutic doses. It also demonstrates some anti-inflammatory activity independent of H1 blockade, though the clinical weight of that additional mechanism is modest. Onset is rapid and duration supports once-daily dosing at 10 mg.

Its indications are seasonal and perennial allergic rhinitis and chronic idiopathic urticaria.

Two constraints worth establishing early. Mizolastine carries cardiac considerations shared with several second-generation antihistamines: it is contraindicated with drugs that prolong the QT interval, with macrolide and imidazole antifungal agents, and in patients with significant cardiac disease or hepatic impairment. Separately, its geographic footprint is narrow — it is a European product, marketed principally in the United Kingdom, France and neighbouring markets, and is not approved in the United States.

Sourcing notes. That narrow footprint is the governing commercial fact. Dossiers and approved manufacturing sites are far fewer than for cetirizine, loratadine or fexofenadine, so supply options are limited and pricing reflects it. Where a buyer's requirement is simply a non-sedating antihistamine rather than mizolastine specifically, the widely genericised alternatives will almost always be quicker to register and cheaper to supply.